Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$712M |
| 2 |
PepsiCo
PEP
|
+$669M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$635M |
| 4 |
Walmart Inc
WMT
|
+$544M |
| 5 |
Palantir
PLTR
|
+$538M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.34B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.65B |
| 3 |
Tesla
TSLA
|
+$1.45B |
| 4 |
Invesco QQQ Trust
QQQ
|
+$1.01B |
| 5 |
Apple
AAPL
|
+$833M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.48% |
| 2 | Financials | 7.27% |
| 3 | Consumer Discretionary | 6.82% |
| 4 | Communication Services | 5.06% |
| 5 | Healthcare | 4.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
Churchill Downs
CHDN
$5.82B
| $7.14M | ﹤0.01% |
73,582
+196
| +0.3% | +$20.2K |
|
1927
CALL
Teva Pharmaceuticals
TEVA
$40.1B
| $7.12M | ﹤0.01% |
+352,500
| New | +$6.19M |
|
1928
GXO Logistics
GXO
$5.82B
| $7.11M | ﹤0.01% |
134,460
+76,419
| +132% | +$3.93M |
|
1929
PUT
Salesforce
CRM
$152B
| $7.11M | ﹤0.01% |
30,000
-276,300
| -90% | -$69.7M |
|
1930
SM Energy
SM
$7.66B
| $7.11M | ﹤0.01% |
284,616
+20,260
| +8% | +$546K |
|
1931
Timken Company
TKR
$9.85B
| $7.1M | ﹤0.01% |
94,468
-12,424
| -12% | -$958K |
|
1932
BCE
BCE
$20.3B
| $7.1M | ﹤0.01% |
303,504
-226,269
| -43% | -$5.45M |
|
1933
State Street Industrial Select Sector SPDR ETF
XLI
$33.9B
| $7.1M | ﹤0.01% |
46,003
-90,021
| -66% | -$13.6M |
|
1934
Outfront Media
OUT
$5.61B
| $7.09M | ﹤0.01% |
387,108
-166,858
| -30% | -$3.03M |
|
1935
Disc Medicine
IRON
$2.93B
| $7.08M | ﹤0.01% |
107,203
+20,645
| +24% | +$1.23M |
|
1936
Winnebago Industries
WGO
$885M
| $7.07M | ﹤0.01% |
211,555
-54,080
| -20% | -$1.78M |
|
1937
PUT
VanEck Oil Services ETF
OIH
$1.94B
| $7.07M | ﹤0.01% |
27,200
| – | – |
|
1938
Xencor
XNCR
$1.44B
| $7.04M | ﹤0.01% |
600,345
-54,052
| -8% | -$469K |
|
|
KALV
1939
DELISTED
KalVista Pharmaceuticals
KALV
| $7.04M | ﹤0.01% |
577,904
+408,981
| +242% | +$5.65M |
|
1940
Asbury Automotive
ABG
$4.09B
| $7.04M | ﹤0.01% |
28,789
-14,577
| -34% | -$3.54M |
|
1941
Pitney Bowes
PBI
$2.48B
| $7.01M | ﹤0.01% |
614,281
+241,363
| +65% | +$2.81M |
|
1942
Marriott Vacations Worldwide
VAC
$3.35B
| $6.99M | ﹤0.01% |
105,048
+25,466
| +32% | +$1.96M |
|
1943
CALL
Verizon
VZ
$195B
| $6.98M | ﹤0.01% |
158,800
-1,176,800
| -88% | -$50.9M |
|
1944
CALL
GE Vernova
GEV
$268B
| $6.95M | ﹤0.01% |
+11,300
| New | +$6.85M |
|
1945
National CineMedia
NCMI
$392M
| $6.95M | ﹤0.01% |
1,540,240
+134,144
| +10% | +$626K |
|
1946
Starwood Property Trust
STWD
$5.92B
| $6.94M | ﹤0.01% |
358,362
-35,109
| -9% | -$707K |
|
|
1947
PUT
State Street Industrial Select Sector SPDR ETF
XLI
$33.9B
| $6.94M | ﹤0.01% |
45,000
-127,000
| -74% | -$19.2M |
|
1948
Bank OZK
OZK
$5.65B
| $6.92M | ﹤0.01% |
135,690
-25,224
| -16% | -$1.29M |
|
1949
Enova International
ENVA
$6.44B
| $6.91M | ﹤0.01% |
60,072
-21,020
| -26% | -$2.4M |
|
1950
Goodyear
GT
$2.02B
| $6.89M | ﹤0.01% |
921,764
+21,167
| +2% | +$199K |
|
Similar funds
Barclays's Q3 2025 Portfolio in Review
As of Q3 2025, Barclays held 5,800 positions worth $461B, up 5.7% from $436B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays's Q3 2025 filing shows 615 new, 1,596 increased, 2,751 reduced and 340 closed positions. Its largest new stake was Paramount Skydance Corp: 13,646,704 shares worth $258M. The largest sale was NVIDIA, an estimated $2.34B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Barclays's largest Q3 2025 buy was Paramount Skydance Corp: 13,646,704 shares worth $258M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q3 2025, an estimated $712M increase.
- Barclays's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $2.34B.
- Barclays fully exited Blueprint Medicines in Q3 2025, selling an estimated $200M.
- Barclays's ten largest holdings make up 40% of its $461B portfolio in Q3 2025.
- Barclays opened 615 new positions and closed 340 in Q3 2025.
- Barclays's portfolio value rose 5.7% quarter-over-quarter to $461B.
Based on Barclays's 13F filing for Q3 2025, filed 12 Nov 2025.